FI120263B - Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi - Google Patents

Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi Download PDF

Info

Publication number
FI120263B
FI120263B FI955382A FI955382A FI120263B FI 120263 B FI120263 B FI 120263B FI 955382 A FI955382 A FI 955382A FI 955382 A FI955382 A FI 955382A FI 120263 B FI120263 B FI 120263B
Authority
FI
Finland
Prior art keywords
acid
formula
acids
anion
preparation
Prior art date
Application number
FI955382A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955382A (fi
FI955382A0 (fi
Inventor
Rudolf Lattrell
Walter Duerckheimer
Peter Schmid
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of FI955382A0 publication Critical patent/FI955382A0/fi
Publication of FI955382A publication Critical patent/FI955382A/fi
Application granted granted Critical
Publication of FI120263B publication Critical patent/FI120263B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI955382A 1994-11-10 1995-11-08 Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi FI120263B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DE4440141 1994-11-10

Publications (3)

Publication Number Publication Date
FI955382A0 FI955382A0 (fi) 1995-11-08
FI955382A FI955382A (fi) 1996-05-11
FI120263B true FI120263B (fi) 2009-08-31

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955382A FI120263B (fi) 1994-11-10 1995-11-08 Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi

Country Status (28)

Country Link
US (1) US5747484A (hu)
EP (1) EP0711774B1 (hu)
JP (1) JP3920939B2 (hu)
KR (1) KR100449191B1 (hu)
CN (1) CN1066452C (hu)
AR (1) AR002246A1 (hu)
AT (1) ATE213248T1 (hu)
AU (1) AU707730B2 (hu)
BR (1) BR9505132A (hu)
CA (1) CA2162530C (hu)
CZ (1) CZ290936B6 (hu)
DE (2) DE4440141A1 (hu)
DK (1) DK0711774T3 (hu)
ES (1) ES2172549T3 (hu)
FI (1) FI120263B (hu)
HU (1) HU219475B (hu)
IL (1) IL115914A (hu)
MA (1) MA23709A1 (hu)
NO (1) NO311891B1 (hu)
NZ (1) NZ280424A (hu)
OA (1) OA10242A (hu)
PL (1) PL182806B1 (hu)
PT (1) PT711774E (hu)
RU (1) RU2161619C2 (hu)
SK (1) SK282545B6 (hu)
TR (1) TR199501392A2 (hu)
TW (1) TW422847B (hu)
ZA (1) ZA959510B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288199A1 (en) * 1997-04-29 1998-11-05 The University Of New Mexico Hydroxynaphthoic acids and derivatives
ATE327759T1 (de) * 2002-10-25 2006-06-15 Akzo Nobel Nv Pharmazeutische zusammensetzung mit verlungerter freisetzung
PL1945223T3 (pl) * 2005-10-29 2010-12-31 Intervet Int Bv Kompozycje cefchinomu i sposoby ich stosowania
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺内感染症の治療方法
EP2750706A4 (en) * 2011-09-29 2015-04-15 Alere San Diego Inc 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
BR112015023523B8 (pt) 2013-03-15 2023-03-07 Merck Sharp & Dohme Composições farmacêuticas e recipiente de forma de dosagem única
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
BR9505132A (pt) 1997-09-09
IL115914A0 (en) 1996-01-31
TW422847B (en) 2001-02-21
NO311891B1 (no) 2002-02-11
ES2172549T3 (es) 2002-10-01
RU2161619C2 (ru) 2001-01-10
PL182806B1 (pl) 2002-03-29
SK282545B6 (sk) 2002-10-08
CZ293395A3 (en) 1996-05-15
TR199501392A2 (tr) 1996-07-21
DE4440141A1 (de) 1996-05-15
NO954511L (no) 1996-05-13
MA23709A1 (fr) 1996-07-01
HU219475B (hu) 2001-04-28
ATE213248T1 (de) 2002-02-15
PL311326A1 (en) 1996-05-13
OA10242A (fr) 1997-09-19
AR002246A1 (es) 1998-03-11
KR100449191B1 (ko) 2006-01-12
CA2162530A1 (en) 1996-05-11
AU707730B2 (en) 1999-07-15
ZA959510B (en) 1996-05-28
AU3772895A (en) 1996-05-16
CA2162530C (en) 2007-07-31
CN1066452C (zh) 2001-05-30
NO954511D0 (no) 1995-11-09
KR960017670A (ko) 1996-06-17
CZ290936B6 (cs) 2002-11-13
FI955382A (fi) 1996-05-11
DK0711774T3 (da) 2002-04-22
HU9503213D0 (en) 1996-01-29
JP3920939B2 (ja) 2007-05-30
PT711774E (pt) 2002-07-31
DE59510048D1 (de) 2002-03-21
US5747484A (en) 1998-05-05
SK139795A3 (en) 1996-06-05
HUT74163A (en) 1996-11-28
JPH08208662A (ja) 1996-08-13
CN1129220A (zh) 1996-08-21
NZ280424A (en) 1997-06-24
FI955382A0 (fi) 1995-11-08
IL115914A (en) 2002-08-14
EP0711774B1 (de) 2002-02-13
EP0711774A1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
FI120263B (fi) Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi
FI56531C (fi) Foerfarande foer framstaellning av isotiocyanobenstiazoler med anthelmintisk och mikrobicid verkan
JP4338217B2 (ja) 置換可能な８―シアノ―１―シクロプロピル―７―（２，８―ジアザビシクロ―［４．３．０］―ノナン―８―イル）―６―フルオロ―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸およびそれらの誘導体
US4382938A (en) Imidazo[1,2-a] pyridine derivatives and their application as pharmaceuticals
US11771712B2 (en) Carborane compounds and methods of use thereof
FI78079B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade 6-(2-aminoetyl)-bensoxazolinoner.
KR100191989B1 (ko) 신규한 결정형의 무수7-((1알파,5알파,6알파)-6-아미노-3-아자비사이클로(3.1.0)헥스-3-일)-6-플루오로-1-(2,4-디플루오로페닐)-1,4-디하이드로-4-옥소-1,8-나프티리딘-3-카복실산 메탄설폰산 염
KR20160108400A (ko) 7-옥소-1,6-디아자바이사이클로[3.2.1]옥탄 유도체 및 이의 항박테리아제로서의 용도
RU2005131735A (ru) Химические соединения
SU1750419A3 (ru) Способ получени производных 4-замещенных бензамидов
RU2058307C1 (ru) Соли 2-морфолино-5-фенил-6н-1,3,4-тиадиазина и 4,7-дигидро-6-нитро-7-оксо-[1,2,4]-триазоло [5,1-с] [1,2,4]-триазинов, обладающие бактерицидной активностью в отношении возбудителя микоплазмоза
BRPI0618276A2 (pt) sal de monofosfato de 7-[4-(4-naftalen-1-il-piperazin-1-il)-butóxi]-3,4-diidro-1h -[1,8]naftiridin-2-ona cristalino, composição, composição farmacêutica, uso desse sal e processo para a sua fabricação
RU2144921C1 (ru) Кристаллическая форма цвиттериона тровафлоксацина и способ ее получения
WO2018035509A2 (en) Small molecules having antiviral properties
JPS58174367A (ja) キノリン誘導体及びその製法
KR0182276B1 (ko) 나프톡사진의 약학적 용도
Massah et al. Mild and solvent-free synthesis and antibacterial evaluation of novel sulfonamides containing hydroxyl groups
SE423387B (sv) Sett att framstella 2-/(p-metoxibensoyl-hydrazon-formyl-kinoxalin-1,4-dioxid
CA3128346A1 (en) Synthetic process and novel intermediates
RU2223791C2 (ru) Способ получения дезинфицирующего средства (варианты)
FI78465C (fi) Foerfarande foer framstaellning av terapeutiskt verkande -oxo- -karbamoylpyrrolpropionitriler.
JPH10505345A (ja) 新規チアゾロ［３，２−ａ］キノリンおよびチアゾロ［３，２−ａ］ナフチリジン誘導体
KR800000144B1 (ko) 벤즈 히드릴 술피닐 유도체의 제조방법
FI74455C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och farmaceutiskt acceptabla salter daerav.
HU194230B (en) Process for preparing 2-/2-thienyl/-imidazo/4,5-c/pyridine derivatives and pharmaceutically acceptable acid addition salts thereof

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

FG Patent granted

Ref document number: 120263

Country of ref document: FI

MA Patent expired